Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 83457

3 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
August 29, 2019
Product types
Drug
Classifications
Class II
Statuses
Terminated
Recalling firm wording
Johnson Matthey Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

3 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 3

Fentanyl Citrate Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001.

D-1880-2019
Recall number
D-1880-2019
Initiated
August 29, 2019
Classification
Class II
Status
Terminated
Recalling firm
Johnson Matthey Inc.
Quantity
52882.23 grams

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations: Potential glass contamination

Code information

Lot #: B0030-180101, B0030-180102, Exp. Feb 2023

Distribution pattern

Nationwide within the United States

drug · product 2 of 3

Cisplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001

D-1881-2019
Recall number
D-1881-2019
Initiated
August 29, 2019
Classification
Class II
Status
Terminated
Recalling firm
Johnson Matthey Inc.
Quantity
26625 grams

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations: Potential glass contamination

Code information

Lot #: B0101-161102, Exp. Dec 2021

Distribution pattern

Nationwide within the United States

drug · product 3 of 3

Oxaliplatin Active Pharmaceutical Ingredient, Johnson Matthey Pharmaceutical Materials 2003 Nolte Drive, West Deptford, NJ 08066-1742 (856) 384-7001, NDC 49821-0075-XX

D-1882-2019
Recall number
D-1882-2019
Initiated
August 29, 2019
Classification
Class II
Status
Terminated
Recalling firm
Johnson Matthey Inc.
Quantity
316703.32

App-derived interpretation

Manufacturing or process control reason.manufacturing_process_control · v1.0.0
cGMP Deviations

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

cGMP Deviations: Potential glass contamination

Code information

Lot #: B0126-170701; B0126-170802; Exp. Sep 2022; B0126-180401, Exp. May 2023; B0126-180702, B0126-180803, Exp. Oct 2023

Distribution pattern

Nationwide within the United States